本页面由Tiger Trade Technology Pte. Ltd.提供服务

Enanta Pharmaceuticals Inc.

13.16
-0.0700-0.53%
成交量:18.80万
成交额:247.49万
市值:3.82亿
市盈率:-5.06
高:13.31
开:13.19
低:13.02
收:13.23
52周最高:17.15
52周最低:5.88
股本:2,901.85万
流通股本:2,083.05万
量比:0.87
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-2.6000
每股收益(LYR):-3.8381
净资产收益率:-59.00%
总资产收益率:-11.84%
市净率:3.28
市盈率(LYR):-3.43

数据加载中...

2021/05/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/06

重要事件披露

8-K - Current report
2021/03/05

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

重要事件披露

8-K - Current report
2021/02/05

重要事件披露

8-K - Current report
2021/01/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/04

重要事件披露

8-K - Current report
2020/11/25

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/11/23

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/04

重要事件披露

8-K - Current report